Back
Dermata Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
DRMA
Dermata Therapeutics, Inc.
Last Price:
$1.28
Seasonality Move:
-37.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Dermata Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.3 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.54 | Sell |
| 200-day SMA: | 3.8 | Sell |
| 8-day EMA: | 1.27 | Buy |
| 20-day EMA: | 1.31 | Sell |
| 50-day EMA: | 1.56 | Sell |
| 200-day EMA: | 5.5 | Sell |
Dermata Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 47.45 | Sell |
| Chaikin Money Flow: | 128481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.15 - 1.39) | Buy |
| Bollinger Bands (100): | (1.38 - 2.7) | Sell |
Dermata Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics, Inc. Stock
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 1.29 while DRMA 8-day simple moving average is 1.30, which is a Sell signal.
-
The stock price of DRMA is 1.29 while Dermata Therapeutics, Inc. 20-day SMA is 1.29, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day simple moving average is 1.54 while DRMA share price is 1.29, making it a Sell technically.
-
DRMA stock price is 1.29 and Dermata Therapeutics, Inc. 200-day simple moving average is 3.80, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
40
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy or a Sell?
-
Dermata Therapeutics, Inc. stock is rated a SellThe current Dermata Therapeutics, Inc. [DRMA] share price is $1.29. The Score for DRMA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics, Inc. Stock Info
Market Cap:
5.5M
Price in USD:
1.29
Share Volume:
154.2K
Dermata Therapeutics, Inc. 52-Week Range
52-Week High:
9.90
52-Week Low:
1.10
Sell
40
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Dermata Therapeutics, Inc. Share Price Forecast
-
What is the Dermata Therapeutics, Inc. stock price today?The Dermata Therapeutics, Inc. stock price is 1.29 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics, Inc. is overvalued.
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 1.29 while DRMA 8-day exponential moving average is 1.27, which is a Buy signal.
-
The stock price of DRMA is 1.29 while Dermata Therapeutics, Inc. 20-day EMA is 1.31, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day exponential moving average is 1.56 while DRMA share price is 1.29, making it a Sell technically.
-
DRMA stock price is 1.29 and Dermata Therapeutics, Inc. 200-day simple moving average is 5.50, creating a Sell signal.
Technical Analysis of Dermata Therapeutics, Inc.
Should I short Dermata Therapeutics, Inc. stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Dermata Therapeutics, Inc. is a Sell
-
Dermata Therapeutics, Inc. Relative Strength Index (RSI) is 47.45, which suggest Dermata Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Dermata Therapeutics, Inc. is (1.15 - 1.39), which suggest Dermata Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Dermata Therapeutics, Inc. is (1.38 - 2.7), which suggest Dermata Therapeutics, Inc. is a Sell
* Dermata Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.